文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

癌症作为全球范围内导致过早死亡的主要原因,其重要性日益增加。

The ever-increasing importance of cancer as a leading cause of premature death worldwide.

机构信息

International Agency for Research on Cancer, Lyon, France.

出版信息

Cancer. 2021 Aug 15;127(16):3029-3030. doi: 10.1002/cncr.33587. Epub 2021 Jun 4.


DOI:10.1002/cncr.33587
PMID:34086348
Abstract

The relative importance of cardiovascular disease (CVD) and cancer as leading causes of premature death are examined in this communication. CVD and cancer are now the leading causes in 127 countries, with CVD leading in 70 countries (including Brazil and India) and cancer leading in 57 countries (including China). Such observations can be seen as part of a late phase of an epidemiologic transition, taking place in the second half of the 20th century and the first half of the present one, in which the dominance of infectious diseases is progressively superseded by noncommunicable diseases. According to present ranks and recent trends, cancer may surpass CVD as the leading cause of premature death in most countries over the course of this century. Clearly, governments must factor in these transitions in developing cancer policies for the local disease profile.

摘要

本通讯探讨了心血管疾病 (CVD) 和癌症作为导致过早死亡的主要原因的相对重要性。目前,在 127 个国家中,心血管疾病和癌症是主要死因,在 70 个国家(包括巴西和印度)中,心血管疾病是主要死因,在 57 个国家(包括中国)中,癌症是主要死因。这些观察结果可以被视为 20 世纪后半叶和本世纪上半叶发生的流行病学转变的后期阶段的一部分,在这一阶段,传染病的主导地位逐渐被非传染性疾病所取代。根据目前的排名和最近的趋势,在本世纪,癌症可能会超过心血管疾病成为大多数国家导致过早死亡的主要原因。显然,各国政府在制定针对当地疾病特征的癌症政策时,必须考虑到这些转变。

相似文献

[1]
The ever-increasing importance of cancer as a leading cause of premature death worldwide.

Cancer. 2021-8-15

[2]
National mortality burden due to communicable, non-communicable, and other diseases in Ethiopia, 1990-2015: findings from the Global Burden of Disease Study 2015.

Popul Health Metr. 2017-7-21

[3]
Trends in premature avertable mortality from non-communicable diseases for 195 countries and territories, 1990-2017: a population-based study.

Lancet Glob Health. 2020-4

[4]
Trends in cause-specific mortality among children aged 5-14 years from 2005 to 2016 in India, China, Brazil, and Mexico: an analysis of nationally representative mortality studies.

Lancet. 2019-3-12

[5]
Global, regional, and national age-sex specific mortality for 264 causes of death, 1980-2016: a systematic analysis for the Global Burden of Disease Study 2016.

Lancet. 2017-9-16

[6]
NCD Countdown 2030: worldwide trends in non-communicable disease mortality and progress towards Sustainable Development Goal target 3.4.

Lancet. 2018-9-20

[7]
Mortality by cause for eight regions of the world: Global Burden of Disease Study.

Lancet. 1997-5-3

[8]
Mortality due to noncommunicable diseases in Brazil, 1990 to 2015, according to estimates from the Global Burden of Disease study.

Sao Paulo Med J. 2017

[9]
Cause-specific mortality for 249 causes in Brazil and states during 1990-2015: a systematic analysis for the global burden of disease study 2015.

Popul Health Metr. 2017-11-22

[10]
National disability-adjusted life years (DALYs) for 257 diseases and injuries in Ethiopia, 1990-2015: findings from the global burden of disease study 2015.

Popul Health Metr. 2017-7-21

引用本文的文献

[1]
NUTM2A-AS1 as a potential key regulator in cancer: unraveling its ceRNA networks and impact on tumor biology.

Eur J Med Res. 2025-9-3

[2]
Global patterns and trends in cancer-related premature death and their impact on life expectancy across 185 countries: a population-based analysis.

Mil Med Res. 2025-9-3

[3]
Application of Mendelian randomization in the discovery of risk factors for cancer from 2014 to 2024: a bibliometric review.

Discov Oncol. 2025-9-3

[4]
Validation of a deep learning-based AI system for HER2-targeted breast cancer assessment using ultrasound imaging in a clinical setting.

Front Oncol. 2025-8-14

[5]
Patient-Generated Subjective Global Assessment and Phase Angle as Predictors of Survival in Cancer Patients.

Cureus. 2025-7-29

[6]
Structure-based drug discovery of novel penta- or hexa-bicyclo-pyrazolone derivatives as potent and selective AXL inhibitors.

RSC Med Chem. 2025-8-9

[7]
Current status of cancer education in developing and developed countries: identifying the disparities and bridging the gap.

Front Public Health. 2025-8-13

[8]
Antibody-functionalized lipid nanocarriers for RNA-based cancer gene therapy: advances and challenges in targeted delivery.

Nanoscale Adv. 2025-8-22

[9]
Quality of life in patients with pan-cancer undergoing concurrent chemoradiotherapy: a bibliometric analysis (1995-2024).

Front Oncol. 2025-8-12

[10]
Pharmacological Potential of Cinnamic Acid and Derivatives: A Comprehensive Review.

Pharmaceuticals (Basel). 2025-7-31

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索